USD 28.62
(1.42%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 2.39 Billion USD | 8.62% |
2022 | 2.2 Billion USD | 19.58% |
2021 | 1.84 Billion USD | 9.05% |
2020 | 1.69 Billion USD | 4.77% |
2019 | 1.61 Billion USD | 15.7% |
2018 | 1.39 Billion USD | 6.98% |
2017 | 1.3 Billion USD | 4.82% |
2016 | 1.24 Billion USD | 2.22% |
2015 | 1.21 Billion USD | 3.05% |
2014 | 1.18 Billion USD | 17.4% |
2013 | 1 Billion USD | 11.65% |
2012 | 901 Million USD | 4.89% |
2011 | 859 Million USD | -6.93% |
2010 | 923 Million USD | -1.07% |
2009 | 933 Million USD | 6.14% |
2008 | 879 Million USD | 5.4% |
2007 | 834 Million USD | 34.73% |
2006 | 619 Million USD | 11.13% |
2005 | 557 Million USD | 1.93% |
2004 | 546.45 Million USD | 32.7% |
2003 | 411.78 Million USD | 11.4% |
2002 | 369.65 Million USD | 9.32% |
2001 | 338.13 Million USD | -0.8% |
2000 | 340.84 Million USD | -11.32% |
1999 | 384.36 Million USD | -4.47% |
1998 | 402.35 Million USD | 7.84% |
1997 | 373.1 Million USD | -5.19% |
1996 | 393.53 Million USD | 15.82% |
1995 | 339.79 Million USD | 11.46% |
1994 | 304.86 Million USD | 5.96% |
1993 | 287.7 Million USD | 0.58% |
1992 | 286.04 Million USD | -11.38% |
1991 | 322.77 Million USD | 0.08% |
1990 | 322.51 Million USD | 6.12% |
1989 | 303.91 Million USD | 14.04% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 2.49 Billion USD | 0.0% |
2023 Q2 | 2.41 Billion USD | 0.0% |
2023 FY | 2.39 Billion USD | 8.62% |
2023 Q4 | 2.39 Billion USD | 0.0% |
2022 Q4 | 2.2 Billion USD | 0.0% |
2022 Q2 | 1.99 Billion USD | 0.0% |
2022 FY | 2.2 Billion USD | 19.58% |
2021 FY | 1.84 Billion USD | 9.05% |
2021 Q2 | 1.75 Billion USD | 0.0% |
2021 Q4 | 1.84 Billion USD | 0.0% |
2020 Q2 | 1.72 Billion USD | 0.0% |
2020 Q4 | 1.69 Billion USD | 0.0% |
2020 FY | 1.69 Billion USD | 4.77% |
2019 FY | 1.61 Billion USD | 15.7% |
2019 Q4 | 1.61 Billion USD | 0.0% |
2019 Q2 | 1.53 Billion USD | 0.0% |
2018 Q4 | 1.39 Billion USD | 0.0% |
2018 Q2 | 1.35 Billion USD | 0.0% |
2018 FY | 1.39 Billion USD | 6.98% |
2017 FY | 1.3 Billion USD | 4.82% |
2017 Q4 | 1.3 Billion USD | 0.0% |
2017 Q2 | 1.29 Billion USD | 0.0% |
2016 Q4 | 1.24 Billion USD | 0.0% |
2016 FY | 1.24 Billion USD | 2.22% |
2016 Q2 | 1.29 Billion USD | 0.0% |
2015 FY | 1.21 Billion USD | 3.05% |
2015 Q2 | 1.18 Billion USD | 0.0% |
2015 Q4 | 1.21 Billion USD | 0.0% |
2014 Q4 | 1.18 Billion USD | 0.0% |
2014 FY | 1.18 Billion USD | 17.4% |
2014 Q2 | 1.18 Billion USD | 0.0% |
2013 Q4 | 1 Billion USD | 0.0% |
2013 Q2 | 933 Million USD | 0.0% |
2013 FY | 1 Billion USD | 11.65% |
2012 Q4 | 901 Million USD | 1.24% |
2012 Q1 | 888 Million USD | 3.38% |
2012 FY | 901 Million USD | 4.89% |
2012 Q2 | 872 Million USD | -1.8% |
2012 Q3 | 890 Million USD | 2.06% |
2011 FY | 859 Million USD | -6.93% |
2011 Q4 | 859 Million USD | -4.98% |
2011 Q3 | 904 Million USD | -4.03% |
2011 Q2 | 942 Million USD | 0.64% |
2011 Q1 | 936 Million USD | 1.41% |
2010 Q1 | 917 Million USD | -1.71% |
2010 Q2 | 906 Million USD | -1.2% |
2010 FY | 923 Million USD | -1.07% |
2010 Q3 | 953 Million USD | 5.19% |
2010 Q4 | 923 Million USD | -3.15% |
2009 FY | 933 Million USD | 6.14% |
2009 Q4 | 933 Million USD | -6.23% |
2009 Q2 | 971 Million USD | 6.94% |
2009 Q3 | 995 Million USD | 2.47% |
2009 Q1 | 908 Million USD | 3.3% |
2008 Q3 | 901 Million USD | -2.17% |
2008 FY | 879 Million USD | 5.4% |
2008 Q1 | 887 Million USD | 5.97% |
2008 Q2 | 921 Million USD | 3.83% |
2008 Q4 | 879 Million USD | -2.44% |
2007 Q1 | 652 Million USD | 5.33% |
2007 Q2 | 830 Million USD | 27.3% |
2007 Q4 | 837 Million USD | -1.65% |
2007 Q3 | 851 Million USD | 2.53% |
2007 FY | 834 Million USD | 34.73% |
2006 Q4 | 619 Million USD | -2.67% |
2006 FY | 619 Million USD | 11.13% |
2006 Q1 | 585 Million USD | 64.79% |
2006 Q2 | 614 Million USD | 4.96% |
2006 Q3 | 636 Million USD | 3.58% |
2005 Q4 | 355 Million USD | -43.92% |
2005 Q3 | 633 Million USD | 2.64% |
2005 Q2 | 616.74 Million USD | 4.0% |
2005 Q1 | 593 Million USD | 8.57% |
2005 FY | 557 Million USD | 1.93% |
2004 Q1 | 448.95 Million USD | 8.84% |
2004 FY | 546.45 Million USD | 32.7% |
2004 Q4 | 546.21 Million USD | 1.72% |
2004 Q3 | 536.97 Million USD | 11.82% |
2004 Q2 | 480.23 Million USD | 6.97% |
2003 Q2 | 399.51 Million USD | 2.37% |
2003 Q1 | 390.28 Million USD | 5.53% |
2003 Q3 | 411.01 Million USD | 2.88% |
2003 FY | 411.78 Million USD | 11.4% |
2003 Q4 | 412.5 Million USD | 0.36% |
2002 Q2 | 370.37 Million USD | 0.0% |
2002 Q4 | 369.83 Million USD | 0.0% |
2002 FY | 369.65 Million USD | 9.32% |
2001 FY | 338.13 Million USD | -0.8% |
2001 Q2 | 318.06 Million USD | 0.0% |
2001 Q4 | 338.13 Million USD | 0.0% |
2000 Q2 | 366.22 Million USD | 0.0% |
2000 Q4 | 340.84 Million USD | 0.0% |
2000 FY | 340.84 Million USD | -11.32% |
1999 Q2 | 396.5 Million USD | 0.0% |
1999 Q4 | 384.36 Million USD | 0.0% |
1999 FY | 384.36 Million USD | -4.47% |
1998 FY | 402.35 Million USD | 7.84% |
1997 FY | 373.1 Million USD | -5.19% |
1996 FY | 393.53 Million USD | 15.82% |
1995 FY | 339.79 Million USD | 11.46% |
1994 FY | 304.86 Million USD | 5.96% |
1993 FY | 287.7 Million USD | 0.58% |
1992 FY | 286.04 Million USD | -11.38% |
1991 FY | 322.77 Million USD | 0.08% |
1990 FY | 322.51 Million USD | 6.12% |
1989 FY | 303.91 Million USD | 14.04% |
Name | Inventory | Inventory Difference |
---|---|---|
Abbott Laboratories | 6.57 Billion USD | 63.546% |
Allurion Technologies Inc. | 6.17 Million USD | -38710.566% |
Artivion, Inc. | 81.97 Million USD | -2821.587% |
Avanos Medical, Inc. | 163.2 Million USD | -1367.525% |
Butterfly Network, Inc. | 75.83 Million USD | -3058.089% |
Butterfly Network, Inc. | 75.83 Million USD | -3058.089% |
Bio-Rad Laboratories, Inc. | 780.51 Million USD | -206.848% |
Boston Scientific Corporation | 2.48 Billion USD | 3.583% |
CONMED Corporation | 318.32 Million USD | -652.378% |
Edwards Lifesciences Corporation | 1.16 Billion USD | -105.016% |
Paragon 28, Inc. | 98.06 Million USD | -2342.332% |
Glaukos Corporation | 41.98 Million USD | -5604.282% |
Globus Medical, Inc. | 848.13 Million USD | -182.384% |
Inspire Medical Systems, Inc. | 33.88 Million USD | -6968.024% |
Integer Holdings Corporation | 239.71 Million USD | -899.099% |
Medtronic plc | 5.21 Billion USD | 54.092% |
Myomo, Inc. | 1.8 Million USD | -132696.823% |
Nevro Corp. | 118.67 Million USD | -1918.1% |
Owlet, Inc. | 6.49 Million USD | -36785.877% |
Penumbra, Inc. | 388.02 Million USD | -517.231% |
Vicarious Surgical Inc. | - USD | -Infinity% |
STERIS plc | 674.53 Million USD | -255.059% |
Stryker Corporation | 4.84 Billion USD | 50.547% |
Vapotherm, Inc. | 22.96 Million USD | -10327.551% |
Zimmer Biomet Holdings, Inc. | 2.38 Billion USD | -0.411% |